HealthCare Royalty Partners
focuses on investing in commercial stage healthcare and life science products and companies... Read moreHealthCare Royalty Partners
focuses on investing in commercial stage healthcare and life science products and companies... Read more
News
Jul 02, 2022
Indian Pharma Post
HealthCare Royalty Partners: Ardelyx gets into $20 million financing agreement with HealthCare Royalty Partners
Jun 23, 2022
Global Legal Chronicle
HealthCare Royalty Partners: Rhythm Pharmaceuticals' $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners
Jun 17, 2022
Benzinga
HealthCare Royalty Partners: Rhythm Pharma Secures Non-Dilutive Financing Of $100M To Use Of This...
Jun 16, 2022
BioSpace
HealthCare Royalty Partners: Rhythm Pharmaceuticals Enters into a Non-dilutive Revenue Interest Financing Agreement with HealthCare Royalty for up to $100 Million
Feb 09, 2022
MarketScreener
HealthCare Royalty Partners: Aptevo Therapeutics : Earns $10 Million Non-Dilutive Milestone Payment on Sales of RUXIENCE, Provides Company Update - Form 8-K
Oct 07, 2021
Global Legal Chronicle
HealthCare Royalty Partners: ADC Therapeutics' $325 Million Royalty Purchase Agreement With HealthCare Royalty
Sep 30, 2021
Benzinga
HealthCare Royalty Partners: Spero Therapeutics Inks Revenue Interest Financing Agreement With HealthCare Royalty Partners
Aug 26, 2021
Benzinga
HealthCare Royalty Partners: ADC Therapeutics Announces $325M Financing Agreement With HealthCare Royalty
Jul 29, 2021
centralcharts
Press Release: HealthCare Royalty Partners : HealthCare Royalty, Inc. Launches Initial Public Offering
Jul 29, 2021
Citybizlist
HealthCare Royalty Partners: HealthCare Royalty Launches IPO
HealthCare Royalty Partners Competitors
1
2
3
4
5
6
7
8
9
10